A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit ...

A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most ...

U.S. Defense Secretary Pete Hegseth says the screenings will boost the military’s readiness and resilience, but doctors ...

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

A prostate cancer treatment used by Jeremy Clarkson is as effective as surgery or radiotherapy but has fewer side effects, a ...

Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...

A retired Utah radiologist shares his experience with robotic surgery after a prostate cancer diagnosis and encourages other men to get screened.

Akeega prostate cancer UK approval: the MHRA has licensed Johnson and Johnson's niraparib-abiraterone combination for men ...

The Himalayas-1 trial will investigate rinzimetostat in combination with darolutamide in patients who previously received abiraterone for metastatic castration-resistant prostate cancer. A phase 3 ...

Telix Pharmaceuticals and St Vincent's Hospital announced the first patients have been dosed with TLX597-Tx in the OPTIMAL-e ...

Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript ...

In a new report of research, scientists at Johns Hopkins University School of Medicine and Johns Hopkins Kimmel Cancer Center ...